Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial

July 13, 2020 updated by: Flory Nkoy, University of Utah

The investigators have developed a tool to facilitate self-management for children with medical complexity (complex, multisystem chronic diseases) called MyChildCMC (My Child's Complex Medical Condition). MyChildCMC is an online, phone application (app) that engages parents daily in ongoing monitoring of common, crosscutting acute symptoms, including respiratory distress, inadequate feeding/fluid intake, fever, altered mental status, pain, and seizure status. The MyChildCMC app also guides parents to recognize early warning signs for health deteriorations to avoid acute events (i.e., ED visits and/or hospitalizations).

Parent comments during the development of the MyChildCMC application revealed that the tool had potential in helping them manage their child's chronic conditions. This study will be the first to explore if online home monitoring using online technology is feasible, scalable, and can lead to improved CMC outcomes. This pilot feasibility trial for the MyChildCMC app will determine app feasibility and if successful, our approach will be a model for improving CMC care and reducing costs for families and children with medical complexity. Future MyChildCMC trials will integrate care coordination and a more robust alert system to help facilitate care and follow-up for patients.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Aim: Investigators will assess the impact of the MyChildCMC app by comparing outcomes for the child and caregiver with the following outcomes:

  1. Child Quality of Life (QOL)
  2. Child Hospital and Emergency Department (ED) admissions
  3. Parent/Caregiver satisfaction with care
  4. Study participation rate
  5. Retention of intervention (intervention arm only)
  6. Adherence of intervention (intervention arm only)

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Utah
      • Salt Lake City, Utah, United States, 84112
        • University of Utah

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Participant Inclusion Criteria:

Children with complex medical conditions* ages 1 through 20 years with their primary caregiver (primary person caring for the child) who:

  • have been seen at Primary Children's Hospital within 365 days,
  • own a smartphone or a tablet computer with Internet access, and
  • are English speaking *Physician diagnosis wa used to determine CMC diagnosis

Exclusion Criteria:

  • Critically ill children in imminent death
  • Non-English speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MyChildCMC Intervention Group
Parents/patients randomized into the MyChildCMC Intervention Group will use the MyChildCMC app to monitor their child's daily symptoms for the duration of the study period (3 months). The MyChildCMC app includes a daily form consisting of 12 questions assessing child's vitals, pain, seizures, mood, and feeding as well as caregiver worry for the day. Daily reminders are sent to the parent to fill out the vitals form in the app. Parents/participants will also fill out a quality of life survey at baseline, 1 month, and 3 months as well as a caregiver satisfaction survey at 3 months.
Patients/parents will self-monitor their symptoms daily using the MyChildCMC app completing the daily vitals form. After patient/parents complete the daily form, the app provides in-app alerts and graphs showing symptom data over time.
No Intervention: Standard of Care Group
Parents/patients randomized into the Standard of Care Group do not use the MyChildCMC app to monitor their child's daily symptoms and are instructed to continue with regular care for their child and to continue monitoring their child's symptoms on their own without the use of the app for the duration of the study period (3 months). Parents/participants will also fill out a quality of life survey at baseline, 1 month, and 3 months as well as a caregiver satisfaction survey at 3 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Quality of Life (QOL)
Time Frame: QUality of Life assessed at baseline, then compared to 1 month and 3 months from start of study/intervention
Compared Mean QOL Change from Baseline to Each Follow-up Assessment Between the Two Intervention Groups, using the QOL survey questionnaire for children with complex medical conditions (adapted from Ellzey et. al), which assesses multiple domains including physical health, mental health, sleep, pain, activities and general QOL.
QUality of Life assessed at baseline, then compared to 1 month and 3 months from start of study/intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Emergency Department (ED)/Hospitalization
Time Frame: Change in ED/hospital admission between 3-month prior and 3-month post start of study/intervention
Compare NUMBER of ED and hospital admissions, 3-month prior the study intervention and 3-month post start of the study intervention.
Change in ED/hospital admission between 3-month prior and 3-month post start of study/intervention
Parent/Caregiver Satisfaction with Care
Time Frame: Collected once at study end (3 months)
Caregiver Satisfaction with overall care of their children, using satisfaction survey questionnaire for children with complex medical conditions (published by Ellzey et. al), which measure, caregiver's confidence with ability to take care of child's health, consistency in doing things needed to take care of the child, availability of medical professional support, availability of social support, availability of a monitory system to help with child's home care.
Collected once at study end (3 months)
Study Participation Rate
Time Frame: Collected once at study end (3 months)
Percentage of eligible subjects who agreed to participate out of those who were approached
Collected once at study end (3 months)
Patient retention to intervention (intervention arm only)
Time Frame: Collected at 1 month and 3 months
Percentage of patient/parents in the intervention arm who completed the final QOL or vitals assessment during the study period
Collected at 1 month and 3 months
Patient adherence to intervention (intervention arm only)
Time Frame: Collected at 1 month and 3 months
Percentage of daily vital signs/symptoms recorded over the 3 month period out of all opportunities
Collected at 1 month and 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Flory Nkoy, MD, MS, MPH, University of Utah

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2019

Primary Completion (Actual)

March 19, 2020

Study Completion (Actual)

March 19, 2020

Study Registration Dates

First Submitted

July 6, 2020

First Submitted That Met QC Criteria

July 13, 2020

First Posted (Actual)

July 14, 2020

Study Record Updates

Last Update Posted (Actual)

July 14, 2020

Last Update Submitted That Met QC Criteria

July 13, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 088596

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children With Medical Complexity

Clinical Trials on MyChildCMC app

3
Subscribe